Celera Diagnostics, Abbott Labs Ink Broad Molecular-Diagnostics Collaboration | GenomeWeb

Click here to view an updated version of this article.

NEW YORK, June 24 - Celera Diagnostics and Abbott Labs will partner to develop and market a "broad range" of in vitro molecular diagnostics to detect and monitor a variety of diseases, the companies said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.